Innovative trial will use psilocybin to target relapse in opioid addiction
Imperial College, October 18, 2024
Imperial researchers will explore the potential for psilocybin therapy in drug recovery as part of a landmark trial.
A ‘first in the UK’ clinical trial exploring the use of psychedelics in addiction.
People Are Trying Magic Mushrooms for Depression — and Accidentally Meeting God
Rolling Stone, August 18, 2024
The article discusses how psychedelics are gaining attention as powerful spiritual tools amid setbacks in the medicalisation movement.
Psychedelic trial for compound headaches
The Australian, August 14, 2024
A rare condition could be treated with psilocybin, as an Australian study doubles down on the nation’s commitment to psychedelic medicine.
‘Danger zone’ for mental health, says global study
The Australian, August 14, 2024
The biggest-ever study of its kind, led by Australian psychiatrists, has found the incidence of mental ill-health in young people has risen by 50% in 15 years.
ASX Health Stocks: Psilocybin drug shows promise for fibromyalgia pain relief
Herald Sun, August 12, 2024
There’s new hope for fibromyalgia sufferers, with all patients in a pivotal trial of a new medicine reporting eased pain, improved sleep, and better quality of life.
Veterans and Lawmakers Lobby in Bipartisan Push for MDMA Therapy
New York Times, August 8, 2024
More than a half-century after federal regulators banned most psychedelic compounds, the Food and Drug Administration is nearing a decision on a novel treatment for post-traumatic stress disorder that pairs talk therapy with MDMA.
The end-of-life patients finding solace in magic mushrooms: ‘What life after life could be like’
The Guardian, August 7, 2024
Psychedelic medicines, like psilocybin, are currently the subject of intensive scientific research for their benefits in treating depression, PTSD and addiction. In cancer patients, like the studies Hartle came across, psilocybin has been shown to reduce existential distress.
Allaying the fears: MDMA with therapy is a medicine
Drug Science, August 6, 2024
Mind Medicine Australia’s Chair Peter Hunt AM co-authored an article with Professor David Nutt (Imperial College London), Tadeusz Hawrot (PAREA – Europe) and Dr Anne Schlag (Drug Science – UK) which analyses the recent decision of the FDA’s Advisory Committee on the proposed registration.
MDMA To Be Used As Trauma Treatment
The Project - CH10, July 1, 2024
Patients like Shannon Foster have struggled with PTSD resulting from childhood and intergenerational family trauma. After a decade of seeing a psychotherapist, earlier this month Shannon tried the new therapy in a Sydney clinic that has become the first in NSW to use MDMA to treat trauma, after it was approved by the TGA following clinical trials.
FDA advisors voted against MDMA therapy – researchers are still fighting for it
BBC, June 20, 2024
A vote against using MDMA as part of therapy for PTSD has provoked a powerful backlash among researchers who study psychedelic medicines.
Psychedelics therapy gets under way in NSW
Medical Republic, June 13, 2024
The state’s first patients have begun treatment with medically enhanced psychotherapy for PTSD and treatment-resistant depression.
Magic Mushrooms Get Canadian Export License in Psychedelic Race
BNN Bloomberg, June 3, 2024
Canada has licensed a startup to export psychedelics to Australia for patient use, the latest milestone in a contest to supply the potential growth of medical psychedelic medicines.
Psilocybin for dementia prevention?
Science Direct, June 1, 2024
The potential role of psilocybin to alter mechanisms associated with major depression and neurodegenerative diseases.
With $2 million raised, MAPS-Israel looks to use psychedelics to treat post-Oct. 7 wave of PTSD
eJewish Philanthropy, May 29, 2024
The Israeli affiliate of the Multidisciplinary Association for Psychedelic Studies plans to use MDMA to combat post-traumatic stress disorder among Nova festival partygoers, residents of the Gaza border region and Israeli soldiers.
The Power and Promise of Psychedelics in Therapy
CNN, May 18, 2024
An interview with Ernesto Londoño, reporter at the New York Times and author of the new book, “Trippy: The Peril and Promise of Medicinal Psychedelics.”
One Dose of LSD-Based Medication Yields Rapid, Durable Response for GAD
Medscape, May 7, 2024
A single oral administration of MM120 (lysergide d-tartrate), an investigational lysergic acid diethylamide (LSD)–based medicine being developed by Mind Medicine Inc (MindMed), provided rapid and durable improvement in generalized anxiety disorder (GAD) in a phase 2B study.
Companies looking to offer psychedelic drug therapy coverage for employees
New York Post, April 12, 2024
A growing number of companies are exploring the possibility of offering psychedelic therapy for their employees as a cost-saving and effective means of mental health treatment, according to a report.
Antidepressant prescriptions soar among UK children
UnHerd, April 2, 2024
New figures suggest nearly 500,000 antidepressant prescriptions are being given to children each year, with only one in four having visited a child psychiatrist before they were given the medicines.
Better sex beyond the trip: Enhanced sexual functioning months after a psychedelic experience
Open Foundation, March 24, 2024
“This study shines yet more light on the far-reaching effects of psychedelics on an array of psychological functioning.” Dr David Erritzoe, Clinical Director of the Centre for Psychedelic Research.
Denver Begins Psychedelic Training For First Responders
Dabbin-Dad, March 17, 2024
MAPS has partnered with the City and County of Denver to provide comprehensive training on psychedelic crisis assessment and intervention to the city’s first responders.